Severe Pneumonia Clinical Trial
Official title:
Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients
This study is a prospective observation study for lower respiratory tract infections in medical intensive care unit. Microbiologic and clinical characteristics and outcomes of patients with severe pneumonia in medical intensive care unit will be monitored and analyzed.
All patients admitting medical ICU will be monitored for pneumonia. Both community-acquired (including health-care associated pneumonia) and hospital-acquired pneumonia will be included. Collecting data will include patient demographic characteristics, clinical features, microbiological characteristics including molecular work, and outcome. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06114784 -
Microbiome and Host Susceptibility in Severe Pneumonia, a Prospective, Multicenter, Cohort Study
|
||
Completed |
NCT03870243 -
Feasibility and Acceptability Followed by Effectiveness of bCPAP for Treatment of Children Aged 1-59 Months With Severe Pneumonia in Ethiopia
|
N/A | |
Completed |
NCT05158842 -
Treatment of COVID-19 Positive/Negative Bangladeshi Adults With Severe Respiratory Complaints by a Locally Made bCPAP: Feasibility Study
|
N/A | |
Suspended |
NCT04310865 -
Yinhu Qingwen Granula for the Treatment of Severe CoVID-19
|
Phase 2/Phase 3 | |
Completed |
NCT04457505 -
One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19
|
||
Terminated |
NCT04794803 -
Reparixin in COVID-19 Pneumonia - Efficacy and Safety
|
Phase 2/Phase 3 | |
Completed |
NCT03831906 -
Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia)
|
N/A | |
Recruiting |
NCT05768204 -
Research on the Treatment of Severe Community-acquired Pneumonia in Children
|
Phase 4 | |
Recruiting |
NCT04359667 -
Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab
|
||
Not yet recruiting |
NCT04395066 -
Molecular Diagnosis and Prognosis of Severe Pulmonary Infection Immunosuppressed Hosts
|
||
Not yet recruiting |
NCT05143593 -
Species-specific Bacterial Detector for Fast Pathogen Diagnosis of Severe Pneumonia
|
N/A | |
Completed |
NCT05663905 -
Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients
|
Phase 4 | |
Not yet recruiting |
NCT04282928 -
Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells for the Treatment of Severe Viral Pneumonian
|
Phase 1 | |
Completed |
NCT01192789 -
Community Case Management of the Severe Pneumonia With Oral Amoxicillin in Children 2-59 Months of Age
|
N/A | |
Completed |
NCT00455468 -
Randomized Controlled Trial (RCT) in Children With Severe Pneumonia
|
N/A | |
Completed |
NCT03588377 -
Impact of Pulse Oximetry on Hospital Referral Acceptance in Children Under 5 With Severe Pneumonia
|
N/A | |
Recruiting |
NCT04955756 -
Early Identification and Severity Prediction of Acute Respiratory Infectious Disease
|
N/A | |
Recruiting |
NCT04882436 -
Construction of Special Disease Cohort Database and Biological Sample Holographic Database of Severe Pneumonia
|
||
Not yet recruiting |
NCT03891212 -
The Effect of Prone Position Drainage on the Efficacy of Severe Pneumonia,a Multicenter Randomized Controlled Trial
|
N/A |